/PRNewswire/ The "Global Lymphoma Antibodies Market & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com s offering. Global.
DUBLIN (BUSINESS WIRE) The "Global Lymphoma Antibodies Market & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.Global lymphoma antibody therapeutics market is expected to surpass US$ 6 Billion by 2028The global lymphoma antibody therapeutics market is set to witness impres.
Press release content from Business Wire. The AP news staff was not involved in its creation.
KSQ® Therapeutics Appoints Qasim Rizvi, MB ChB., M.B.A., as Chief Executive Officer
January 25, 2021 GMT
Qasim Rizvi, MB.ChB. (Photo: Business Wire)
CAMBRIDGE, Mass. (BUSINESS WIRE) Jan 25, 2021
KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics ® discovery platform to systematically screen the whole genome to identify optimal gene targets for oncology and autoimmune disease, today announced it has appointed Qasim Rizvi as chief executive officer. Dr. Rizvi joins KSQ today as CEO and will also become a member of the company’s board of directors. Dr. Rizvi is a highly accomplished healthcare executive with broad experience in the biopharmaceuticals industry and was most recently senior vice president of operations and chief commercial officer at Kiniksa Pharmaceuticals.